Literature DB >> 22810988

Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys.

May A Beydoun1, J Atilio Canas, Hind A Beydoun, Xiaoli Chen, Monal R Shroff, Alan B Zonderman.   

Abstract

Specific micronutrients, including retinol, retinyl esters, carotenoids [α-carotene, β-carotene (cis+trans), β-cryptoxanthin, lutein+zeaxanthin, and total lycopene], vitamin E, and vitamin C have antiinflammatory and antioxidant effects, properties shown to reduce oxidative stress, a process that accompanies the pathogenesis of many chronic diseases. It is still largely unknown whether they are associated with the occurrence of metabolic syndrome (MetS) in the adolescent U.S. population. MetS was defined by the International Diabetes Federation (IDF) criteria. Other non-MetS outcomes relying on blood measurements were elevated HOMA-IR, C-reactive protein (CRP), and hyperuricemia. We tested associations between serum antioxidants and MetS outcomes among adolescents aged 12-19 y using cross-sectional data from NHANES 2001-2006 (n = 782-4285). IDF MetS prevalence was estimated at 7% among boys and 3% among girls. In adjusted models, adolescents with MetS had consistently lower carotenoid concentrations compared with their counterparts without MetS. Total carotenoids were also inversely related to HOMA-IR and CRP. Vitamin C was inversely related to uric acid level and MetS binary outcome. Retinol+retinyl esters exhibited an inverse relationship with CRP and a positive relationship with uric acid and HOMA-IR as well as MetS binary outcome. Vitamin E had no association with MetS, particularly after controlling for serum cholesterol and TG. In conclusion, among U.S. adolescents, serum carotenoid concentrations were inversely associated with MetS status, HOMA-IR, and CRP, whereas serum vitamin C was inversely related to MetS status and serum uric acid. Vitamin E had no consistent association with MetS, whereas retinol+retinyl esters had a positive relationship with HOMA-IR, uric acid, and MetS, while being inversely related to CRP. These associations need further study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810988      PMCID: PMC3417831          DOI: 10.3945/jn.112.160416

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  101 in total

Review 1.  Childhood obesity and adult morbidities.

Authors:  Frank M Biro; Michelle Wien
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

2.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

Authors:  Timothy E Graham; Qin Yang; Matthias Blüher; Ann Hammarstedt; Theodore P Ciaraldi; Robert R Henry; Christopher J Wason; Andreas Oberbach; Per-Anders Jansson; Ulf Smith; Barbara B Kahn
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

4.  Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents.

Authors:  M L Neuhouser; C L Rock; A L Eldridge; A R Kristal; R E Patterson; D A Cooper; D Neumark-Sztainer; L J Cheskin; M D Thornquist
Journal:  J Nutr       Date:  2001-08       Impact factor: 4.798

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  Reduced antioxidant status in obese children with multimetabolic syndrome.

Authors:  D Molnár; T Decsi; B Koletzko
Journal:  Int J Obes Relat Metab Disord       Date:  2004-10

7.  Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus.

Authors:  Ching-Chu Chen; Jer-Yuarn Wu; Chwen-Tzuei Chang; Fuu-Jen Tsai; Tzu-Yuan Wang; Yi-Min Liu; Huai-Chih Tsui; Rong-Hsing Chen; Shyh-Ching Chiou
Journal:  Metabolism       Date:  2009-08-25       Impact factor: 8.694

8.  Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults.

Authors:  Jared P Reis; Denise von Mühlen; Edgar R Miller
Journal:  Eur J Endocrinol       Date:  2008-04-21       Impact factor: 6.664

9.  The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Ali H Mokdad; Wayne H Giles; David W Brown
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

Review 10.  Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis.

Authors:  Patrice Carter; Laura J Gray; Jacqui Troughton; Kamlesh Khunti; Melanie J Davies
Journal:  BMJ       Date:  2010-08-18
View more
  29 in total

Review 1.  Seaweeds as potential therapeutic interventions for the metabolic syndrome.

Authors:  Senthil Arun Kumar; Lindsay Brown
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

2.  Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.

Authors:  Xiang Qiu; Dan-Hong Gao; Xiao Xiang; Yu-Fang Xiong; Teng-Shi Zhu; Lie-Gang Liu; Xiu-Fa Sun; Li-Ping Hao
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Plasma n-3 polyunsaturated fatty status and its relationship with vitamin E intake and plasma level.

Authors:  Yang Zhao; Frank J Monahan; Breige A McNulty; Kaifeng Li; Frederick J Bloomfield; Daniel J Duff; Lorraine Brennan; Anne P Nugent; Eileen R Gibney
Journal:  Eur J Nutr       Date:  2016-02-29       Impact factor: 5.614

4.  Race differences in the relation of vitamins A, C, E, and β-carotene to metabolic and inflammatory biomarkers.

Authors:  Edward C Suarez; Nicole L Schramm-Sapyta
Journal:  Nutr Res       Date:  2013-10-14       Impact factor: 3.315

5.  Reduced antioxidant capacity and increased subclinical inflammation markers in prepubescent obese children and their relationship with nutritional markers and metabolic parameters.

Authors:  Aysel Vehapoglu; Serdar Turkmen; Nilufer Goknar; Ömer Faruk Özer
Journal:  Redox Rep       Date:  2016-02-19       Impact factor: 4.412

6.  Effects of Mixed Carotenoids on Adipokines and Abdominal Adiposity in Children: A Pilot Study.

Authors:  J Atilio Canas; Amanda Lochrie; Amy Galena McGowan; Jobayer Hossain; Christopher Schettino; P Babu Balagopal
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

Review 7.  Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols-The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer.

Authors:  Piotr Olcha; Anna Winiarska-Mieczan; Małgorzata Kwiecień; Łukasz Nowakowski; Andrzej Miturski; Andrzej Semczuk; Bożena Kiczorowska; Krzysztof Gałczyński
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

8.  Gene polymorphisms and gene scores linked to low serum carotenoid status and their associations with metabolic disturbance and depressive symptoms in African-American adults.

Authors:  May A Beydoun; Michael A Nalls; J Atilio Canas; Michele K Evans; Alan B Zonderman
Journal:  Br J Nutr       Date:  2014-09-28       Impact factor: 3.718

9.  Carotenoids, vitamin A, and their association with the metabolic syndrome: a systematic review and meta-analysis.

Authors:  May A Beydoun; Xiaoli Chen; Kanishk Jha; Hind A Beydoun; Alan B Zonderman; Jose A Canas
Journal:  Nutr Rev       Date:  2019-01-01       Impact factor: 7.110

10.  Inflammation and oxidative stress are associated with the prevalence of high aankle-brachial index in metabolic syndrome patients without chronic renal failure.

Authors:  Yinyin Zhang; Jie Chen; Kun Zhang; Minyi Kong; Tao Wang; Renhua Chen; Lily Wang; Jingfeng Wang; Hui Huang
Journal:  Int J Med Sci       Date:  2013-01-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.